Millennium Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-561,826
| Closed | -$1.82M | – | 4419 |
|
|
2024
Q3 | $1.82M | Buy |
561,826
+497,469
| +773% | +$1.61M | ﹤0.01% | 2601 |
|
|
2024
Q2 | $193K | Sell |
64,357
-277,093
| -81% | -$831K | ﹤0.01% | 3580 |
|
|
2024
Q1 | $1.59M | Buy |
341,450
+142,549
| +72% | +$663K | ﹤0.01% | 2719 |
|
|
2023
Q4 | $823K | Sell |
198,901
-45,300
| -19% | -$188K | ﹤0.01% | 2935 |
|
|
2023
Q3 | $733K | Sell |
244,201
-99,774
| -29% | -$299K | ﹤0.01% | 3069 |
|
|
2023
Q2 | $846K | Buy |
343,975
+141,647
| +70% | +$348K | ﹤0.01% | 3008 |
|
|
2023
Q1 | $457K | Sell |
202,328
-859,446
| -81% | -$1.94M | ﹤0.01% | 3472 |
|
|
2022
Q4 | $3.71M | Buy |
1,061,774
+1,042,044
| +5,282% | +$3.64M | ﹤0.01% | 2306 |
|
|
2022
Q3 | $730K | Sell |
19,730
-98,780
| -83% | -$3.65M | ﹤0.01% | 3559 |
|
|
2022
Q2 | $2.25M | Sell |
118,510
-161,079
| -58% | -$3.06M | ﹤0.01% | 2791 |
|
|
2022
Q1 | $7.55M | Sell |
279,589
-274,403
| -50% | -$7.41M | ﹤0.01% | 1885 |
|
|
2021
Q4 | $12.5M | Buy |
553,992
+299,412
| +118% | +$6.75M | 0.01% | 1380 |
|
|
2021
Q3 | $6.67M | Buy |
254,580
+238,351
| +1,469% | +$6.25M | ﹤0.01% | 1907 |
|
|
2021
Q2 | $519K | Buy |
16,229
+9,860
| +155% | +$315K | ﹤0.01% | 4174 |
|
|
2021
Q1 | $224K | Sell |
6,369
-18,561
| -74% | -$653K | ﹤0.01% | 4103 |
|
|
2020
Q4 | $800K | Buy |
+24,930
| New | +$800K | ﹤0.01% | 3003 |
|
|
2020
Q3 | – | Sell |
-43,328
| Closed | -$1.94M | – | 3844 |
|
|
2020
Q2 | $1.94M | Buy |
43,328
+4,905
| +13% | +$220K | ﹤0.01% | 2048 |
|
|
2020
Q1 | $1.31M | Buy |
38,423
+15,222
| +66% | +$519K | ﹤0.01% | 1846 |
|
|
2019
Q4 | $905K | Buy |
+23,201
| New | +$905K | ﹤0.01% | 2473 |
|